Back to EveryPatent.com
United States Patent |
5,286,646
|
Kearns
,   et al.
|
February 15, 1994
|
Method for mammalian cell culture
Abstract
The invention presents a method for the culturing of mammalian cells. This
method involves the use of a bioreactor, which contains a sample of
mammalian cells in a culture medium containing large molecules. Positioned
inside the bioreactor is a semipermeable membrane which defines a space
separated from the bioreactor by the semipermeable membrane. A nutrient
medium flows through this separated space and, via virtue of the
semipermeable nature of the separating membrane, nutrient pass
therethrough into the culture medium, while cellular waste products pass
into the separated space. The semipermeable membrane is selected so that
the cells and large molecules, such as proteinaceous materials, cannot
pass through the membrane, but remain in the bioreactor.
Inventors:
|
Kearns; Michael J. (Seeshaupt, DE);
Comer; Michael J. (Bernried, DE);
Steegmans; Ulrich (Tutzing, DE);
Jungfer; Herbert (Tutzing, DE)
|
Assignee:
|
Boehringer Mannheim GmbH (Mannheim, DE)
|
Appl. No.:
|
763867 |
Filed:
|
September 20, 1991 |
Foreign Application Priority Data
Current U.S. Class: |
435/400; 435/401 |
Intern'l Class: |
C12N 005/06 |
Field of Search: |
435/240.1,240.22,240.242,240.24,240.25,240.241,286,284,311,316,813
210/641,649,650
|
References Cited
U.S. Patent Documents
3769176 | Oct., 1973 | Hise et al. | 435/313.
|
3911140 | Oct., 1975 | Osborne et al. | 426/36.
|
3926738 | Dec., 1975 | Nyiri et al. | 435/290.
|
4075100 | Feb., 1978 | Furuta et al. | 210/500.
|
4391912 | Jul., 1983 | Yoshida et al. | 435/284.
|
4440853 | Apr., 1984 | Michaels et al. | 435/284.
|
4559299 | Dec., 1985 | Rotman | 435/240.
|
4647539 | Mar., 1987 | Bach | 435/284.
|
4722902 | Feb., 1988 | Harm et al. | 435/311.
|
Foreign Patent Documents |
0039055 | Apr., 1981 | DE.
| |
0112155 | Dec., 1983 | DE.
| |
2238759 | Jul., 1973 | FR.
| |
Other References
Feder et al., "The Large-Scale Cultivation of Mammalian Cells", Scientific
American, Jan. 1993 pp. 36-43.
Gibco, BRL Catalogue & Reference Guide (1990) p. 96.
Gel Filtration: Theory & Practice, p. 27 (see table 7).
Cheryan et al. In Membrane Separations in Biotech. McGregor (eds) Marcel
Dekker Inc. 1986 (see FIG. 15).
Gori, G. B., (1965) Chemostatic Dialyzed Cell Cultures, vol. 13, pp. 93-98.
Kearns, M. J., (1990) Bio/Technology, vol. 8, pp. 409-413.
Patent Abstracts of Japan, vol. 10, No. 67 (C-333) [2124] Mar. 15, 1986.
M. W. Glacken, "Mammalian Cell Culture: Engineering Principles and
Scale-up" Trends in Biotechnology, vol. 1, No. 4, 1983, pp. 102-108.
|
Primary Examiner: Warden; Robert J.
Assistant Examiner: Trembley; Theresa A.
Attorney, Agent or Firm: Felfe & Lynch
Parent Case Text
This application is a continuation of application Ser. No. 07/409,959,
filed Sep. 18, 1989, which application is a continuation of application
Ser. No. 934,662 filed Nov. 25, 1986, both now abandoned.
Claims
We claim:
1. In a process for culturing mammalian cells for production of biological
products in a batch fermenter having means for monitoring and controlling
the environmental conditions of the cells and wherein the cells are in
homogeneous suspension the improvement comprising
a) maintaining and culturing mammalian cells in a homogeneous suspension to
a final concentration of more than 1.5.times.10.sup.6 /ml in a batch
fermenter which contains a cell culture medium containing high molecular
weight proteinaceous material required for mammalian cell proliferation,
b) providing a nutrient medium, without transporting any high molecular
weight proteinaceous material therewith, to the cells while simultaneously
maintaining the high molecular weight proteinaceous materials within the
cell culture medium in situ by means of a device inside said batch
fermenter being in contact with the cell culture medium, said device
containing a multiplicity of hollow fibers which multiplicity of hollow
fibers are freely immersed in the cell culture medium contained in the
batch fermenter said multiplicity of hollow fibers having an outer
semipermeable membrane and an inner hollow space wherein the outer
semipermeable membranes have an exchange surface of less than 0.3m.sup.2
per liter of cell culture medium, wherein the cell culture medium is in
revolving motion to continuously flow past the multiplicity of hollow
fibers without damage to the cells and wherein the inner hollow space of
the multiplicity of hollow fibers is connected to a source of the nutrient
medium and the nutrient medium passes to the cells and cell waste from the
cell culture medium passes to the nutrient medium to minimize the presence
of cell waste in the cell culture medium via the outer semipermeable
membrane of the hollow fiber, wherein the high molecular weight
proteinaceous material of the cell culture medium is maintained in situ
and cannot pass the semipermeable membrane of the hollow fibers.
2. Process of claim 1 wherein said outer semipermeable membrane has an
exchange surface of from 0.01 m.sup.2 /liter to less than 0.3 m.sup.2
/liter of cell culture medium.
3. Method of claim 2 wherein said outer semipermeable membrane has an
exchange surface of from 0.03 m.sup.2 /liter to 0.2m.sup.2 liter of cell
culture medium.
4. Process of claim 1 wherein said mammalian cells are kept in revolving
motion by a stirring means which comprises at least one marine impeller.
5. Process of claim 1, wherein said mammalian cells are suspension cells.
6. Process of claim 1, wherein said mammalian cells are adherent cells on
micro-carriers.
7. Process of claim 1, wherein said outer semipermeable membrane comprises
cuprammonium rayon fabric.
8. Process of claim 1, wherein said outer semipermeable membrane comprises
cellulose acetate.
9. Process of claim 1, wherein said outer semipermeable membrane comprises
an acrylic copolymer.
10. Process of claim 1, wherein said outer semipermeable membrane comprises
a polysulphone fabric.
11. Process of claim 1, wherein said outer semipermeable permits passage of
molecules with molecular weight up to 100,000 daltons.
12. Process of claim 1, wherein said outer semipermeable permits passage of
molecules with molecular weight up to 10,000 daltons.
Description
FIELD OF THE INVENTION
The present invention is concerned with a process and device for the
biotechnological culturing of cells and especially for the multiplication
of mammalian cells in vitro.
BACKGROUND AND PRIOR ART
In the scope of biotechnology, there are produced biological products, for
example monoclonal antibodies, interferons, vaccines, plasminogen
activators and the like, with the help of cells and especially of
mammalian cells. However, the economics of such processes depend
essentially upon the cells multiplying as much as possible and upon the
highest possible concentration of the desired substance being produced in
the interior of the cells. In order to achieve these objects, special
requirements are demanded of the processes and devices used for the large
scale culturing of cells. Thus, in particular, provision must be made for
a sufficient supply of nutrients, as well as of gases, particularly
oxygen. Waste products, i.e. cell metabolic products, which are not needed
in the cell culture and which frequently inhibit growth of the cells, must
be removed. All other environmental conditions, for example temperature
and pH value, must also be as optimal as possible.
In an article entitled "Mammalian cell culture: engineering principles and
scale-up" by M. W. Glacken et al. in the periodical "Trends in
Biotechnology", pp. 102-108/1983, there are discussed these problems and a
number of constructional principles for appropriate apparatus for the
culturing of cells.
As can be seen from this article, it is necessary to differentiate between
suspension cells and carrier-dependent cells. Whereas the suspension cells
float freely in the cell culture medium and can grow therein,
carrier-dependent cells, which are also called adherent cells, require a
solid carrier in order to be able to survive and grow.
In this article, besides the above-mentioned problems, there are, in
particular, discussed the problems of "upscaling". Thus, it has been found
that methods which function adequately on a laboratory scale are
unsuitable for large-scale production.
Traditionally, mammalian cells, as well as bacterial cells, are primarily
cultured as suspension cultures in bioreactors which are also called
fermenters. The environmental conditions can be precisely controlled in
such vessels. A stirring means moves the culture medium in the interior of
the reactor and thus provides for a homogeneous distribution of the cells.
A corresponding culture technique is also possible for adherent cells in
that they are present on small carrier spheroids which are referred to as
"micro-carriers". These float in the culture medium.
The supply of nutrients to the cells and the removal of waste materials
takes place, in the case of suspension cultures in bioreactors, according
to one of the following three processes:
In a batch operation, the reactor is operated discontinuously. At the
beginning of a batch, the culture medium usually contains a serum, for
example fetal calf serum (FCS), and the necessary nutrients, for example
glucose, vitamins, amino acids and minerals. In operation, these are
consumed so that the medium becomes more and more impoverished in
nutrients. At the same time, the concentration of waste products increases
which finally results in a prevention of the cell growth. The result of
this is a course of cell density curve such as is shown in FIG. 1a of the
accompanying drawings. The cell density achieves a maximum value of about
10.sup.6 cells/ml. and thereafter decreases again. Consequently, the
culturing is discontinued when the maximum cell density is achieved. The
contents of the reactor is then passed on for further working up. This
process is unsatisfactory insofar as the environment of the cells changes
continuously so that, during most of the time of the fermentation
procedure, it is by no means optimal.
This could be improved by repeatedly refreshing the culture medium without
thereby removing cells. However, for this purpose, a part of the culture
medium must be repeatedly removed even though it has by no means been
consumed. Such a process is extremely expensive because the known culture
media are difficult to obtain and, consequently, are expensive.
Better in this regard is the so-called "feedbatch process" in which, during
the fermentation procedure, fresh culture medium is not supplied in its
totality but only the consumed nutrients are continuously supplied.
However, in practice this process does not provide any substantial
advantages because the increase of the waste materials leads to a
characteristic course of the cell density during the culturing procedure
similar to that in the case of the purely batch process.
The third process is the continuous process in a so-called chemostat or
cytostat. Here, the environmental conditions can be uniformly adjusted so
that the cells can grow optimally. However, the process is very laborious
and expensive because culture medium must be continuously supplied and
removed. Furthermore, in the case of this process too, there is not
achieved a substantially higher cell density than in the case of the
above-mentioned processes because cells are also continuously removed from
the reactor with the running off of cell culture medium.
Regardless of which of the three described operational processes is chosen
for the suspension cultures, the results are not satisfactory especially
because the consumption of valuable culture medium is too high and because
a higher maximum cell density is desirable. This latter criterion is of
especial importance because present experience shows that the
concentration of the desired products in the cells increases with
increasing cell density. Therefore, an increase of the cell density leads
to an overproportional increase of the yield of product.
In order to achieve a further improvement, new processes have been
suggested.
The so-called "systems with artificial capillaries" consist essentially of
a bundle of hollow dialysis fibres which are arranged in the interior of a
hollow cylinder. They are especially recommended for the culturing of
adherent cells. The cells are thereby applied to the outer side of the
hollow fibres and are present in the intermediate spaces between the
hollow fibres within the cylindrical housing. A culture medium flows
through the inner side of the capillaries and air is supplied to the cells
through the outer side of the housing. With such a process, there is
achieved a comparatively uniform and economic supply of the nutrients to
the cells. The cell density can also be slightly increased. Although the
supply of nutrients is uniform, nevertheless it has been shown that the
cells are supplied to a varying extent. This is especially due to the fact
that they are positioned on the capillaries in several layers. The supply
of oxygen is thereby also limited which can result in an increased
production of waste products.
Such hollow fibre fermenters are described in European Patent
Specifications Nos. 0,112,154 and 0,112,155. In the latter Specification,
the system is varied insofar as the cells are pumped by means of a pump in
circulation through the culturing module.
Hollow fibers, the walls of which consist of a membrane material, are also
used in the cell culturing process described in published Japanese Patent
Specification No. 60-207581. The hollow fibers are present in the culture
medium in the inner chamber of a fermenter. The inside of the hollow
fibers is connected with the outside of the fermenter via a single pipe
which serves not only for the supply but also for the removal of liquids.
With the help of a pump, waste materials of the cells are sucked off
through this pipe through the wall of the hollow fibres or, in a cycle
chronologically separate therefrom, sterilized water, which does not harm
the cells, is introduced. Nutrients for cells can possibly also be added
to this sterilized water. In operation, pumping into the culture liquid
and sucking out therefrom is carried out alternatingly. This cycle is
repeated continuously. In order to avoid the disadvantages of this
discontinuous method of operation, there is preferably used an even number
of hollow fibre bundles which are operated alternatingly, i.e. while
sucking off from the culture medium through one half of the hollow fibre
bundles, liquid is introduced through the other half of the fibre bundles.
This process is comparatively laborious and involves the danger that the
hollow fibres are damaged by the continuously alternating pressure loading
from one side to the other.
Another novel technique involves the enclosure of the cells in spheroidal
microbodies made of a semipermeable membrane material. This is indicated
in the cited article as the sole new process for the culturing of
suspension cells. It leads to an increase of the cell density in the small
spheroidal bodies which, in turn, results in an increase of the product
yield. The harvesting of the cells is simple because the spheroidal bodies
settle out due to gravity, whereas individual cells must, as a rule, be
centrifuged. These advantages are countered by the very high costs for the
encapsulation of the cells. Furthermore, the supply of oxygen to the cells
is limited which, in turn, reduces the success of the culturing.
DESCRIPTION OF THE INVENTION
Based upon this background, it is an object of the present invention to
provide a simple and economic process and an appropriate device for
culturing cells which makes possible an increased cell density and,
consequently, an increased product yield.
Thus, according to the present invention, there is provided a process for
culturing cells in which a cell culture in a reactor is kept in
substantially homogeneous suspension under controlled environnental
conditions, nutrients for the cells are introduced and cell waste products
are removed, wherein there is used a nutrient medium separate from the
culture medium, which nutrient medium flows in a cycle in a flow path
separated from the culture medium by a semipermeable membrane, the
membrane being such that it is permeable for the nutrients and the cell
waste products but is impermeable for high molecular weight components of
the culture medium, the culture medium with the cells is passed by on one
side of the membrane and the nutrient medium containing the nutrients is
passed by on the other side of the membrane so that nutrients from the
nutrient medium pass through the membrane into the culture medium and
waste materials pass from the culture medium into the nutrient medium.
The membrane is preferably arranged inside the reactor and the culture
medium is preferably passed by it in such a manner that it is in the
reactor chamber. The membrane is preferably in the form of hollow fibres
through the inner space of which is pumped the nutrient medium.
The present invention also provides a device for culturing cells comprising
a reactor, devices for controlling definite environmental conditions and
stirring means for a culture medium present in the inner chamber thereof,
wherein a semipermeable membrane dialyser is provided which separates a
first chamber from a second chamber, said first chamber being connected to
a reservoir for nutrient medium via an inlet pipe and a return pipe and
said second chamber being connected with the inner chamber of the reactor,
and having a device for introducing nutrient medium from the nutrient
medium reservoir via an inlet pipe to the first chamber and for returning
from the first chamber via the return pipe to the reservoir and for
passing the culture medium on the side of the membrane lying opposite the
first chamber.
The membrane is preferably in the form of hollow fibres and is preferably
arranged in the reactor, the second chamber being a part of the inner
chamber of the reactor. The exchanger surface of the dialysator is
preferably at least 0.01 m.sup.2 /liter and at most 0.3 m.sup.2 /liter of
culture medium and more preferably at least 0.03 m.sup.2 /liter and at
most 0.2 m.sup.2 /liter of culture medium. Furthermore, the stirring means
preferably comprises at least one marine impeller.
The present invention is based upon the bioreactor, the inner chamber of
which contains the cells. It is especially suitable for suspension cells
but can also be used for adherent cells, especially when these are present
on micro-carriers such as is described in the cited article. In the
reactor, the cells are kept in substantially homogeneous suspension with
the help of a stirring device. The environmental conditions, i.e.
especially the temperature, the oxygen partial pressure and the pH value,
are controlled with the processes known for bioreactors and are kept
constant in the optimum range.
An important difference with regard to the known processes is, in the case
of the present invention, the fact that the nutrients are supplied to the
cells and the waste products are removed from the cells. This takes place
with the help of a semipermeable membrane which separates two chambers
from one another. To one side of the membrane is supplied the culture
medium from the inner chamber of the reactor. Besides the cells, it
contains, in particular, the proteinaceous substances always contained in
the known culture media, especially the above-mentioned fetal calf serum.
Separate from the culture medium is a nutrient medium which only contains
the relatively low molecular weight nutrients which are continuously
utilized by the cells.
A semipermeable membrane is a separating wall through which some molecules
can diffuse whereas other molecules are held back. For the present
invention, the permeability of the membrane must be such that it is
permeable for the relatively low molecular weight nutrients of the cells,
as well as for their waste products, whereas it is impermeable for the
higher molecular weight components of the culture medium. Consequently,
the membrane firmly holds the high molecular weight and especially the
valuable components of the culture medium. During the culturing procedure,
they are practically not consumed so that they do not have to be
introduced. The low molecular weight nutrients, on the other hand, can
pass through the membrane so that on both sides of the membrane
substantially the same concentration of these materials prevails. The
similar thing also applies to the waste products of the cells which pass
from the culture medium through the membrane into the nutrient medium.
Both media are kept in movement in such a manner that they continuously
flow past the side of the membrane in question. In this way, on the one
hand, there is continuously maintained on the nutrient medium side of the
membrane a sufficiently high nutrient concentration and a sufficiently low
waste material concentration and, on the other hand, the culture medium as
a whole is so substantially homogeneous that substantially optimum growth
conditions for the cells prevail overall. More particularly, the
concentration of the nutrients in the nutrient medium, the rate of flow
with which the nutrient medium flows past the dialysis membrane and the
exchange surface of the dialysis membrane, as well as the rate of flow
with which the culture medium flows past the membrane, must be so adapted
to one another that, in the stationary state, the concentration of the
nutrients in the culture medium is optimized and that the concentration of
the waste materials in the culture medium is so small that the growth of
the cells is not substantially disturbed.
Surprisingly, we have found that, in this way, with the help of a dialysis
membrane, not only its immediate proximity in the dialyser but the whole
inner chamber of a bioreactor can be supplied extraordinarily well with
nutrients and that the waste products can be kept at such a low
concentration that they scarcely disturb the growth. Over all, there is
thus achieved, as is described in more detail hereinafter, cell densities
and product yields which are far superior to those of the conventional
suspension cultures. Nevertheless, the process is simple and very well
suited for large scale production.
The semipermeable membrane can be formed as a flat surface which separates
two appropriate chambers. It can also be made in the form of a tube or a
plate dialyser can be used. Membrane hollow fibres are especially
preferably used. The nutrient medium thereby preferably flows in the
interior of the hollow fibres, whereas the culture medium flows over the
outer side of the hollow fibres.
A first embodiment of the present invention, which is especially suitable
for the equipment of bioreactors already available, provides that the
membrane is arranged outside of the bioreactor. The membrane is present in
a housing in which it separates two chambers. This unit is hereinafter
called a dialyser. The nutrient medium side of the membrane, which in the
case of a hollow fibre dialyser is preferably the interior of the hollow
fibres, is thereby connected with a supply tank for the nutrient solution.
By means of a pump, the nutrient solution is pumped in circulation through
the dialyser and back into the supply container. In a second circulation,
the culture medium is removed from the bioreactor, also pumped through the
dialyser on the culture medium side of the membrane and back again into
the bioreactor.
In comparison therewith, a version is especially preferred in which the
membrane is arranged in the bioreactor. In the case of membrane hollow
fibres, this can be achieved in such a way that the hollow fibre bundle,
which is provided on both ends with appropriate connection heads, is
freely arranged in the bioreactor. In this case, the culture medium is
passed along the semipermeable membrane by means of a stirrer device
present in the bioreactor. The stirring device is preferably so adjusted
that a rotation of the culture medium is achieved with a high exchange of
the medium in the region of the membrane.
Surprisingly, in the case of this simple process, there is achieved a
sufficiently good exchange between nutrient medium and culture medium. Due
to the open arrangement of the membrane in the interior of the bioreactor,
there are no narrow canals in which there could result a stoppage due to
the cells or the proteinaceous components of the medium.
Instead of the hollow fibre dialyser, there can also be used some other
form of membrane, even though this is less preferred, arranged in
appropriate manner in the interior of the bioreactor
The present invention provides, in particular, the following advantages:
the cell density is approximately ten times greater than in the case of
the conventional suspension culture processes in bioreactors. It is
achieved in about 8 days and approaches asymptotically a maximum value
(see FIG. 1c of the accompanying drawings), i.e. a drop of the cell
density does not occur after achievement of the maximum. Consequently, it
is not necessary continuously to supervise the culturing procedure in
order to ascertain the optimal point of time for harvesting the cells. The
concentrations of the nutrients and of the toxic waste products are almost
constant and can very readily be optimized.
The product yields are, especially because of the high cell density, up to
30 times as high as in the case of the conventional processes.
Very much less culture medium is utilized. Consequently, there is a large
saving, especially of serum. This is, in part, also associated with the
high cell density because the same amount of culture medium suffices in
the case of the process according to the present invention for the
production of a very much greater amount of cells and cell products. In
addition, as already mentioned, the serum, in contradistinction to the
mentioned perfusion process, does not have to be renewed or supplemented
during the processing of a batch, only the substantially more economic
nutrients being consumed.
In comparison with the above-mentioned new processes (cell culture on
synthetic capillaries, encapsulation in membrane capsules), which in part
also achieve a really high cell density, the present invention is, in
particular, superior in that in the bioreactor the environnental
conditions can be achieved and regulated very exactly. Thus, for example,
the pH value and the oxygen partial pressure can be continuously measured
and appropriately corrected. Because of the homogeneity of the suspension
in the bioreactor, the values are overall substantially the same.
Furthermore, the process according to the present invention is extremely
simple. The investment costs are comparatively small, the possibilities of
upscaling are very good and no laborious additional process steps, such as
in the case of encapsulation, are required.
DESCRIPTION OF FIGURES AND OF PREFERRED EMBODIMENTS
The present invention and the advantages which are achieved therewith are
explained in more detail in the following on the basis of embodimental
examples which are illustrated in FIGS. 2 and 3. In the accompanying
drawings:
FIG. 1a to FIG. 1c show the chronological development of cell density in
various suspension cell cultures in the bioreactor on about the same
scale, namely, FIG. 1a for a simple batch operation, FIG. 1b for operation
with a continuously supplied culture medium (chemostat) and FIG. 1c for
the process according to the present invention:
FIG. 2 is a schematic illustration of a device according to the present
invention in which a dialyser with the membrane is present outside of the
bioreactor; and
FIG. 3 is a schematic illustration of a device according to the present
invention in which the membrane is present in the bioreactor.
The bioreactor 10 illustrated in FIG. 2 is filled with a culture medium 12.
This culture medium contains high molecular weight proteinaceous
components, especially sera, for example fetal calf serum. A stirring
device 14 is provided for the homogenization of the culture medium. This
consists essentially of a motor 16, an axle 18 passing through the wall of
the reactor and stirring elements 20 fixed thereon. The stirring elements
20 are preferably made like propellers (so-called propeller impellers).
Such a form of stirring elements, which are characterized by rounded
boundary lines and a slope of the angle of incidence of the stirrer blades
increasing continuously from outside towards the inside, has proved to be
especially preferable in order to achieve the degree of homogenization of
the culture medium necessary for the present invention without damaging
the extremely sensitive cells of the culture.
The inner chamber of the bioreactor 10 is connected via pipes 22 and 24
with a dialyser 26. The schematic illustration shows a hollow fibre
dialyser which is preferably used. It is constructed in a manner similar
to that which is usual in the case of dialysers for blood dialysis
(so-called artificial kidneys). In the drawing, on both ends of the
dialyser there can be seen a connection head 30. The hollow fibres 28 run
between the connection heads. The connection heads are so constructed that
the open ends of the hollow fibres are in hydraulic connection with the
connection pipes 32 and 33 for the dialysate. Thus, the inner spaces of
the hollow fibres and the connecting canals up to the connection pipes
form, connected with one another, a first chamber 34 which can be called
the dialysate chamber. This is completely separate from a second chamber
36 formed on the outer side of the hollow fibres through which chamber 36
the culture medium flows. It is bounded essentially by the preferably
substantially cylindrical wall 38 of the dialyser 26 and by the outer
surfaces of the hollow fibres 28. Further details as to how such a
dialyser can, for example, be constructed, are given in European Patent
Specification No. 0,039,055, which is concerned with a blood dialyser.
The culture medium is introduced by means of a pump 40 via the pipe 22 to
the described second chamber 36 of the dialyser, flows along on the side
of the dialysis membrane associated with the culture medium and flows back
via the pipe 24 into the bioreactor 10.
Nutrient medium 44 is present in a nutrient medium tank 42. This medium
consists of an appropriate carrier liquid and various low molecular weight
components which are needed for the nutrition of the cells, which include
glucose, vitamins, amino acids and minerals. By means of a pump 46,
nutrient medium is introduced via the pipe 48 into the dialysis chamber 34
of the dialyser 26. It there flows through the hollow fibers 28 and flows
back through the pipe 50 into the nutrient medium tank 42.
The nutrient medium 44 in the nutrient medium tank 42 is renewed or
supplemented sufficiently frequently that the desired nutrient
concentration on the nutrient medium side of the dialysis membrane is
maintained. This can be achieved either in that the nutrient medium tank
42 is so large that the change of the nutrient concentration taking place
in the course of a culturing procedure does not disturb or the culture
medium can be renewed during a culturing procedure. A continuous
introduction of nutrients, which maintains the concentration in the
nutrient medium tank 42, can also be advantageous.
Instead of the illustrated manner of operation, a hollow fiber dialyser can
also h=introduced into the two circulations for the nutrient medium, on
the one hand, and the culture medium, on the other hand, in such a manner
that the culture medium flows through the interior of the hollow fibers,
whereas the nutrient medium flows over their outer side. However, this is
less preferred because there is a danger of a stoppage of the hollow
fibres by the cells.
Instead of a hollow fibre dialyser, there can also be used another known
type of dialyser. In any case, it is important that the first chamber of
the dialyser for the nutrient medium and the second chamber of the
dialyser for the culture medium, which, of course, must be completely
separate from one another, are so constructed that an exchange is only
possible via the dialysis membrane so that the necessary exchange surface
is ensured For the process according to the present invention, the
exchange surface is preferably from 0.01 m.sup.2 /liter of culture medium
to 0.03 m.sup.2 liter of culture medium and is especially preferably from
0.03 m.sup.2 to 0.2 m.sup.2 /liter of culture medium. Furthermore, the
course of flow, especially in the second chamber 36 through which the
culture medium flows, must be such that the cells can never cause a
blockage and the culture medium can flow through the chamber as
smoothsurfacedly as possible.
The dialysis membranes can be produced from a large number of materials
known for such purpose. In particular, there are known cellulose acetate,
acrylic copolymers and polysulphone fibers. Fibers made from cuprammonium
rayon are especially preferred for the present invention. It is important
that the membrane is permeable for the low molecular weight nutrients but
is impermeable for the high molecular weight proteinaceous substances of
the culture medium. In practice, there has proved to be useful a membrane
with a molecular cut-off at a molecular weight of about 10,000 daltons but
a membrane with a molecular cut-off of 100,000 daltons can also be
preferred in individual cases.
The bioreactor is provided with devices 57 for monitoring and maintaining
constant the environmental conditions for the cells in the culture medium
12. In particular, there are provided sensors for the pH value, the oxygen
partial pressure and the temperature in the bioreactor 10. In the drawing,
they are indicated in their totality by the reference numeral 52. The
devices 57 for monitoring and maintaining constant the environmental
conditions also include a pipe 54 for the introduction of gases through
which, in particular, oxygen is introduced and a pipe 56 for the
introduction of acid and/or alkali with the help of which the pH value is
controlled. These devices 57 are generally known for suspension cultures
in bioreactors. However, the present invention is especially characterized
in that it not only makes possible, as in the case of the known
bioreactors, a very precise control of the temperature, of the oxygen
partial pressure and of the pH value but also that, at the same time, the
concentrations of the nutrients and of the waste products of the cells can
be well controlled and kept substantially constant in a range which makes
possible an optimum cell growth.
FIG. 3 shows an especially preferred embodiment of a device according to
the present invention which, in comparison with the embodiment illustrated
in FIG. 2, differs in that the semipermeable membrane is arranged in the
bioreactor. In this Figure, the corresponding parts have the same
reference numerals as in FIG. 2 but with an additional stroke.
In the case of this embodiment of the present invention, membrane hollow
fibres 28' are used which are freely stretched between the two connection
heads 30' within the bioreactor 10' and form a dialyser 26', the hollow
fibre bundles of which are not surrounded by a housing wall. The
connection heads 30' are secured by means of an appropriate holding means
60' to wall 62' of the bioreactor 10' As in the case of the embodiment
according to FIG. 2, here too the pipe 48', the dialysate chamber 34'
(which is formed by the hollow chambers in the connection heads 30' and
the inner chambers of the hollow fibres 28') and the pipe 50' form a
closed circulation for the nutrient medium 44'. An exchange between the
nutrient medium 44' and the culture medium 12' in the bioreactor 10' is
only possible via the walls of the hollow fibres 28' acting as dialysis
membrane.
In the case of this embodiment, the culture medium is not introduced in a
closed circulation to the second chamber of the dialyser provided for the
culture medium but rather is rotated in the bioreactor in such a manner
that in the region of the surroundings of the dialyser 26' it is in
constant movement and is passed past the dialysis membrane. Thus, in this
case, the second chamber of the dialyser is not a closed chamber but
rather forms a non-bounded part of the inner chamber of the bioreactor
10'. Surprisingly, such a simple construction gives an excellent result.
On the one hand, the exchange of the nutrients and of the waste materials
via the dialysis membrane is so good that the concentration thereof in the
bioreactor can be kept substantially constant in the optimum range. On the
other hand, the problems possibly observed with an embodiment according to
FIG. 2 of a stoppage of the pipes for the culture medium can be dependably
avoided in the case of this embodiment.
The device according to the present invention is preferably operated in the
following manner:
The culture medium is placed, together with a starting culture of the
cells, into the bioreactor and this is closed. Thereafter, the pumps and
stirring devices, as well as the devices for controlling the environnental
conditions, are set into operation so that the culturing procedure can
take place. During the culturing procedure, the plant must merely be
monitored and care taken that the nutrient concentration is maintained in
the above-described manner.
During the operation, on the membrane of the dialyser there flows past, on
the one hand, the nutrient medium and, on the other hand, the culture
medium with controlled speed. The low molecular weight components of both
media are exchanged via the dialysis membrane. The speed with which, on
the one hand, nutrients pass over from the nutrient medium into the
culture medium and, on the other hand, the waste products of the cells
from the culture medium into the nutrient medium is, as is known,
dependent upon the concentrations of the materials in question on both
sides of the membrane and upon the membrane surface. The material
concentrations on both sides depend, in turn, upon the starting
concentrations in the reservoirs, thus, on the one hand, in the bioreactor
and, on the other hand, in the nutrient medium store, as well as upon the
speed with which the media flow past the membrane. Because of these known
relationships, it is possible so to adjust the individual parameters that
during the culturing the nutrient concentration and the waste material
concentration in the culture medium in the bioreactor lie in the optimum
range. After a running-in phase, in the case of appropriate adjustment, a
stationary state is obtained in which not only the nutrient concentration
but also the waste material concentration are substantially constant
Since, as mentioned, the other environmental conditions are kept constant
in the optimum range, the cell culture grows in the manner illustrated in
FIG. 1c until the cell density has achieved a maximum value which is much
higher than in the case of the known culturing processes. This value
remains substantially constant. When it is achieved, the bioreactor can be
opened and the cell culture harvested in known manner.
In the following Table, there are given the results which can be achieved
with the process according to the present invention and an appropriate
device and compared with the results of the cell culturing in a bioreactor
suspension culture which was operated in a batch operation without a
dialyser. The results are given for four different hybridoma cell lines.
It can be seen from the Table that, depending upon the cell type, there is
achieved an improvement of the maximum cell density of between about a
factor of 6 and a factor of 12. The maximum antibody concentration in the
culture is even more considerably greater improved, namely, by a factor of
12 up to a factor of more than 30.
TABLE
______________________________________
maximum antibody
maximum cell density
concentration
(number per ml.)
(.mu.g./ml.)
bioreactor bioreactor
known culture known culture
batch according
batch according
cell bioreactor
to bioreactor
to
line origin culture invention
culture invention
______________________________________
1 mouse 10.sup.6 6 .times. 10.sup.6
20 300
2 human 1.5 .times. 10.sup.6
2 .times. 10.sup.7
0.3 11
3 human 1.5 .times. 10.sup.6
10.sup.7
0.5 13
4 human 1.5 .times. 10.sup.6
10.sup.7
0.8 10
______________________________________
While there have been described what are at present considered to be the
preferred embodiments of this invention, it will be obvious to one skilled
in the art that various changes and modifications may be made therein
without departing from the invention, and it is, therefore, aimed to cover
all such changes and modifications as fall within the spirit and scope of
the invention.
Top